This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Novocure Gmbh, Other. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021-2025
Title: Carsten Hagemann: Innovator in Blood Brain Barrier Research
Introduction
Carsten Hagemann is a notable inventor based in Unterpleichfeld, Germany. He has made significant contributions to the field of medical technology, particularly in enhancing the permeability of the blood-brain barrier (BBB) through innovative methods.
Latest Patents
Hagemann holds 5 patents, with his latest inventions focusing on the use of alternating electric fields to increase the permeability of the blood-brain barrier. One of his key patents describes how applying alternating electric fields at specific frequencies, such as 100 kHz, can temporarily make the BBB permeable to various drugs and molecules that typically cannot cross this barrier. Once the electric fields are turned off, the BBB gradually returns to its original state. This method allows for the introduction of large molecules into the brain, which can be crucial for treating various neurological conditions.
Career Highlights
Throughout his career, Hagemann has worked with several companies, including Novocure GmbH. His work has been instrumental in advancing techniques that could potentially revolutionize drug delivery systems for neurological therapies.
Collaborations
Hagemann has collaborated with notable colleagues such as Mario Lohr and Almuth F Kessler, contributing to the development of innovative solutions in his field.
Conclusion
Carsten Hagemann's work in enhancing the permeability of the blood-brain barrier through alternating electric fields represents a significant advancement in medical technology. His inventions hold the potential to improve treatment options for patients with neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile